Darko stanojevic biography sampler
•
Legend
- Journal
- Article
- Book
- Chapter
- Open Access
We kindly inform you that, as long as the subject affiliation of our 300.000+ articles is in progress, you might get unsufficient or no results on your third level or second level search. In this case, please broaden your search criteria.
Snowflake model of regional competitiveness: Evidence from Serbia
Author(s): Darko Vuković,Dušan Marković,Azra Hanić / Language(s): English Issue: 1-2/2016
The competitiveness of the region is ability to be productive and maintain a high standard of living. In this paper, we have created Snowflake model of regional competitiveness considering not only economic and social factors, but also infrastructure, innovations, geo-natural variables, institutional factors, culture and tourism. This model can be applied in any country or group of countries. The model shows the competitiveness of the region in three ways: 1) quantitatively - by the index
•
Search results
- APPLICATION OF COMPUTERS IN MODERNIZATION OF TEACHING SCIENCE
Dragana Stanojevic; Dragan Cenic; Stojan Cenic International Journal of Cognitive Research in Science, Engineering and Education, 2018, Volume: 6, Issue: 2
Journal Article
Available for: DOBA, IZUM, KILJ, NUK, PILJ, PNG, SAZU, SIK, UILJ, UKNU, UL, UM, UPUK
- Effects of 6-months of oral ferrous and ferric supplement therapy in patients who were hospitalized for decompensated chronic heart failure
Zdravkovic, Snezana Ciric; Nagorni, Svetlana Petrovic; Cojbasic, Irena ... Journal of international medical research, 07/2019, Volume: 47, Issue: 7
Journal Article
Available for: NUK, UL, UM, UPUK
- A review of the risk and precipitating factors for spontaneous coronary arte
•
. Author manuscript; available in PMC: 2025 Feb 1.Published in sista edited form as: Cytotherapy. 2023 Nov 7;26(2):103–112. doi: 10.1016/j.jcyt.2023.10.005
Abstract
Quality control testing and analytics are critical for the development and manufacture of cell and gene therapies, and flow cytometry is a key quality control and analytical assay that is used extensively. However, the technical scope of characterization assays and safety assays must keep apace as the breadth of cell therapy products continues to expand beyond hematopoietic stem cell products into producing novel adoptive immune therapies and gene therapy products. Flow cytometry services are uniquely positioned to support the evolving needs of cell therapy facilities, as tillgång to flow cytometers, new antibody clones, and improved fluorochrome reagents becomes more egalitarian. This report will outline the features, logistics, limitations, and the current state of flow cytometry within the context of cellular ther